DHMEQ racemate is primarily used in research to study its inhibitory effects on NF-κB activation, a key regulator of inflammation and immune responses. It is applied in experimental models to understand its potential in treating inflammatory diseases, cancer, and autoimmune disorders. Researchers utilize it to explore its ability to suppress inflammatory cytokines and inhibit tumor growth, providing insights into therapeutic strategies. Its role in modulating cellular pathways makes it a valuable tool in biomedical studies aimed at developing novel treatments for conditions driven by NF-κB dysregulation.